PKY Completes $2.5m Placement and Launches Rights Issue
Filed with ASX · · 5 pages · English
Story so far
Earlier from Pathkey.AI
- Trading Halt
- Pathkey.AI and Armstrong Clinical Partner on AI Trials
- TrialKeys AI Predictions Continue to Outperform
- Pathkey Advances TrialKey with Drug-Level AI Features
- Successful TrialKey Observational Predictions
Later from Pathkey.AI
- Offer Document
- Quarterly Activities & Cashflow Report
- Response to ASX Price and Volume Query
- PKY - Appendix 4D & Half Year Results
- PKY Secures Key Commercial Contract with Imunexus
Follow Pathkey.AI into a list and get an email when it puts out news.
Follow Pathkey.AI